These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 28209987)
1. Targeting phospholipase D in cancer, infection and neurodegenerative disorders. Brown HA; Thomas PG; Lindsley CW Nat Rev Drug Discov; 2017 May; 16(5):351-367. PubMed ID: 28209987 [TBL] [Abstract][Full Text] [Related]
2. Structural Insights for Drugs Developed for Phospholipase D Enzymes. Stieglitz KA Curr Drug Discov Technol; 2018; 15(2):81-93. PubMed ID: 28814238 [TBL] [Abstract][Full Text] [Related]
3. Structure and regulation of human phospholipase D. Bowling FZ; Frohman MA; Airola MV Adv Biol Regul; 2021 Jan; 79():100783. PubMed ID: 33495125 [TBL] [Abstract][Full Text] [Related]
4. Prospects for PLD Inhibition in Cancer and Thrombotic Disease. Salazar C; Frohman MA Handb Exp Pharmacol; 2020; 259():79-88. PubMed ID: 31541323 [TBL] [Abstract][Full Text] [Related]
5. Mammalian phospholipase D physiological and pathological roles. Peng X; Frohman MA Acta Physiol (Oxf); 2012 Feb; 204(2):219-26. PubMed ID: 21447092 [TBL] [Abstract][Full Text] [Related]
6. Phospholipase D and the Mitogen Phosphatidic Acid in Human Disease: Inhibitors of PLD at the Crossroads of Phospholipid Biology and Cancer. Gomez-Cambronero J; Shah KN Handb Exp Pharmacol; 2020; 259():89-113. PubMed ID: 31541319 [TBL] [Abstract][Full Text] [Related]
7. Signalling roles of mammalian phospholipase D1 and D2. Cockcroft S Cell Mol Life Sci; 2001 Oct; 58(11):1674-87. PubMed ID: 11706993 [TBL] [Abstract][Full Text] [Related]
8. Proliferative and metastatic roles for Phospholipase D in mouse models of cancer. Roth E; Frohman MA Adv Biol Regul; 2018 Jan; 67():134-140. PubMed ID: 29154090 [TBL] [Abstract][Full Text] [Related]
9. Discovery of desketoraloxifene analogues as inhibitors of mammalian, Pseudomonas aeruginosa, and NAPE phospholipase D enzymes. Scott SA; Spencer CT; O'Reilly MC; Brown KA; Lavieri RR; Cho CH; Jung DI; Larock RC; Brown HA; Lindsley CW ACS Chem Biol; 2015 Feb; 10(2):421-32. PubMed ID: 25384256 [TBL] [Abstract][Full Text] [Related]
10. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Scott SA; Selvy PE; Buck JR; Cho HP; Criswell TL; Thomas AL; Armstrong MD; Arteaga CL; Lindsley CW; Brown HA Nat Chem Biol; 2009 Feb; 5(2):108-17. PubMed ID: 19136975 [TBL] [Abstract][Full Text] [Related]
11. Targeting Phospholipase D Genetically and Pharmacologically for Studying Leukocyte Function. Gomez-Cambronero J; Ganesan R Methods Mol Biol; 2018; 1835():297-314. PubMed ID: 30109659 [TBL] [Abstract][Full Text] [Related]
12. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells. Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892 [TBL] [Abstract][Full Text] [Related]
14. Human phospholipase D activity transiently regulates pyrimidine biosynthesis in malignant gliomas. Mathews TP; Hill S; Rose KL; Ivanova PT; Lindsley CW; Brown HA ACS Chem Biol; 2015 May; 10(5):1258-68. PubMed ID: 25646564 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity. Lavieri R; Scott SA; Lewis JA; Selvy PE; Armstrong MD; Alex Brown H; Lindsley CW Bioorg Med Chem Lett; 2009 Apr; 19(8):2240-3. PubMed ID: 19299128 [TBL] [Abstract][Full Text] [Related]
16. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins. Jenco JM; Rawlingson A; Daniels B; Morris AJ Biochemistry; 1998 Apr; 37(14):4901-9. PubMed ID: 9538008 [TBL] [Abstract][Full Text] [Related]
17. The phospholipase D superfamily as therapeutic targets. Frohman MA Trends Pharmacol Sci; 2015 Mar; 36(3):137-44. PubMed ID: 25661257 [TBL] [Abstract][Full Text] [Related]
18. Phospholipase D as a key modulator of cancer progression. Yao Y; Wang X; Li H; Fan J; Qian X; Li H; Xu Y Biol Rev Camb Philos Soc; 2020 Aug; 95(4):911-935. PubMed ID: 32073216 [TBL] [Abstract][Full Text] [Related]
19. Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis. Su W; Chen Q; Frohman MA Future Oncol; 2009 Nov; 5(9):1477-86. PubMed ID: 19903073 [TBL] [Abstract][Full Text] [Related]
20. Physiological and pathophysiological roles for phospholipase D. Nelson RK; Frohman MA J Lipid Res; 2015 Dec; 56(12):2229-37. PubMed ID: 25926691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]